Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120100883 | 12010088 | 3 | F | 20160803 | 20160205 | 20160811 | PER | US-BAYER-2016-022128 | BAYER | 0.00 | A | F | Y | 86.62000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120100883 | 12010088 | 1 | PS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 120100883 | 12010088 | 2 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | UNK | 0 | FILM-COATED TABLET | ||||||||||
| 120100883 | 12010088 | 3 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120100883 | 12010088 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120100883 | 12010088 | Cardiovascular disorder | |
| 120100883 | 12010088 | Mental disorder | |
| 120100883 | 12010088 | Musculoskeletal injury | |
| 120100883 | 12010088 | Nervous system disorder | |
| 120100883 | 12010088 | Neuropathy peripheral | |
| 120100883 | 12010088 | Pain | |
| 120100883 | 12010088 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120100883 | 12010088 | 1 | 2012 | 0 |